Role of SFRP5 in Non-Small Cell Lung Cancer and Its Correlation with SUV of 18F-FDG PET-CT

被引:0
|
作者
Zhang, Na [1 ]
Bai, Tian [1 ]
Jiang, Yunfei [2 ]
Zhu, Kun [3 ]
Yao, Lan [4 ]
Ji, Jia [5 ]
Huang, Qicheng [1 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 3, Radiog Imaging Ctr, Qiqihar, Peoples R China
[2] Qiqihar Med Univ, Affiliated Hosp 3, Resp Dept, Qiqihar, Peoples R China
[3] Qiqihar Med Univ, Affiliated Hosp 3, Cardiothorac Surg Dept, Qiqihar, Peoples R China
[4] Qiqihar Med Univ, Affiliated Hosp 3, Nucl Med Dept, Qiqihar, Peoples R China
[5] Qiqihar Med Univ, Affiliated Hosp 3, Stomatol Dept, Qiqihar, Peoples R China
关键词
SFRP5; non-small cell lung cancer; 18F-FDG PET-CT; cell proliferation; cell metastasis; WNT; EXPRESSION; MUTATION; MARKERS;
D O I
10.1080/08941939.2024.2381722
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim: This study aimed to evaluate the relationship between secreted frizzled-related protein 5 (SFRP5) expression and fluorine 18-fluoro-deoxyglucose (18 F-FDG) uptake imaged with positron emission tomography/tomography (PET/CT) in patients with non-small cell lung cancer (NSCLC). In addition, we sought to elucidate the potential role and mechanism of action of SFRP5 in NSCLC.Materials and methods: The maximum standardized uptake value (SUVmax) of the lesions was calculated. SFRP5 expression was analyzed using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). The correlation between SFRP5 expression and SUVmax was evaluated using Pearson's correlation analysis. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), flow cytometry, wound healing, and transwell assays were used to analyze cell viability, apoptosis, migration, and invasion, respectively.Results and conclusion: The results indicated that the SUVmax was higher in patients with NSCLC than that in healthy volunteers. Moreover, SFRP5 expression was lower in tissues from the four types of NSCLC than that in the adjacent normal tissues. SUVmax negatively correlated with SFRP5 expression in the four types of NSCLC. In addition, up-regulation of SFRP5 decreased the viability, migration, and invasion abilities, and increased apoptosis of NSCLC cells. Furthermore, SFRP5 inhibited the Wnt/beta-catenin pathway in NSCLC cells. In conclusion, SFRP5 modulates the biological behaviors of NSCLC through Wnt/beta-catenin pathway.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] A Retrospective Analysis of 18F-FDG PET/CT in the Primary Staging of Non-Small Cell Lung Cancer (NSCLC)
    Ozkan, E.
    Araz, M.
    Soydal, C.
    Aras, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S125 - S125
  • [42] Coparsion of 18F-FDG hybrid PET and CT in mediastinal staging of non-small cell lung cancer.
    Dakhel, M
    Sharabi, A
    Gillooley, J
    Correte, L
    Bonfils, E
    El-Zeftawy, H
    Perone, R
    Heiba, S
    Abdel-Dayem, HM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 151P - 152P
  • [43] The role of PET with 18F-FDG in small cell lung cancer.
    Zhao, DS
    Valdivia, A
    Li, Y
    Blaufox, MD
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 75P - 75P
  • [44] Correlation of Ki-67/MIB-1 immunohistochemistry with SUV on 18F-FDG PET uptake in non-small cell lung cancer.
    Mestre-Fusco, A.
    Pijuan, L.
    Trampal, C.
    Simo, M.
    Juanpere, N.
    Baro, T.
    Gispert, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S296 - S296
  • [45] The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer
    Zer, A.
    Domachevsky, L.
    Rapson, Y.
    Nidam, M.
    Flex, D.
    Allen, A. M.
    Stemmer, S. M.
    Groshar, D.
    Bernstine, H.
    [J]. EUROPEAN RADIOLOGY, 2016, 26 (09) : 3155 - 3161
  • [46] The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer
    A. Zer
    L. Domachevsky
    Y. Rapson
    M. Nidam
    D. Flex
    A. M. Allen
    S. M. Stemmer
    D. Groshar
    H. Bernstine
    [J]. European Radiology, 2016, 26 : 3155 - 3161
  • [47] Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer
    Kaira, Kyoichi
    Oriuchi, Noboru
    Shimizu, Kimihiro
    Ishikita, Tomohiro
    Higuchi, Tetsuya
    Imai, Hisao
    Yanagitani, Noriko
    Sunaga, Noriaki
    Hisada, Takeshi
    Ishizuka, Tamotsu
    Kanai, Yoshikatsu
    Endou, Hitoshi
    Nakajima, Takashi
    Endo, Keigo
    Mori, Masatomo
    [J]. CANCER SCIENCE, 2009, 100 (04) : 753 - 758
  • [48] Comparison of 18F-FLT PET and 18F-FDG PET for preoperative staging in non-small cell lung cancer
    Yamamoto, Yuka
    Nishiyama, Yoshihiro
    Kimura, Naruhide
    Ishikawa, Shinya
    Okuda, Masaya
    Bandoh, Shuji
    Kanaji, Nobuhiro
    Asakura, Masato
    Ohkawa, Motoomi
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (02) : 236 - 245
  • [49] Comparison of 18F-FLT PET and 18F-FDG PET for preoperative staging in non-small cell lung cancer
    Yuka Yamamoto
    Yoshihiro Nishiyama
    Naruhide Kimura
    Shinya Ishikawa
    Masaya Okuda
    Shuji Bandoh
    Nobuhiro Kanaji
    Masato Asakura
    Motoomi Ohkawa
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 236 - 245
  • [50] Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer
    de Geus-Oei, Lioe-Fee
    van der Heijden, Henricus F. M.
    Visser, Eric P.
    Hermsen, Rick
    van Hoorn, Bas A.
    Timmer-Bonte, Johanna N. H.
    Willemsen, Antoon T.
    Pruim, Jan
    Corstens, Frans H. M.
    Krabbe, Paul F. M.
    Oyen, Wim J. G.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (10) : 1592 - 1598